Ticker Details
Axsome Therapeutics, Inc. Axsome Therapeutics Inc is a pharmaceutical company in the United States. It focuses on developing novel therapeutics for the redressal of diseases related to the central nervous system.
IPO Date:	November 19, 2015
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$9.15B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.23 | 2.88%
Avg Daily Range (30 D):	$2.61 | 1.60%
Avg Daily Range (90 D):	$2.68 | 1.62%

Institutional Daily Volume
Avg Daily Volume:	.61M
Avg Daily Volume (30 D):	.44M
Avg Daily Volume (90 D):	.5M

Trade Size
Avg Trade Size (Sh.):	74
Avg Trade Size (Sh.) (30 D):	35
Avg Trade Size (Sh.) (90 D):	39

Institutional Trades
Total Institutional Trades:	3,627
Avg Institutional Trade:	$3.43M
Avg Institutional Trade (30 D):	$11.69M
Avg Institutional Trade (90 D):	$10.52M
Avg Institutional Trade Volume:	.05M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$4.35M
Avg Closing Trade (30 D):	$16.32M
Avg Closing Trade (90 D):	$13.49M
Avg Closing Volume:	55.07K

News

Apr 8, 2026 @ 11:00 AM Axsome Therapeutics to Report First Quarter 2026 F... Source: Not Specified

Mar 25, 2026 @ 9:24 PM Prediction: 2 Stocks That Will Be Worth More Than ... Source: Prosper Junior Bakiny

Feb 26, 2026 @ 5:07 PM Psychedelic Medicine Advances: Here Are Five Compa... Source: Prnewswire

Jan 8, 2026 @ 3:06 PM Biotech Is Heating Up—These 2 Red-Hot Stock... Source: Nathan Reiff

Jan 8, 2026 @ 10:15 AM 2 Healthcare Stocks to Buy for 2026 and Beyond Source: Prosper Junior Bakiny

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-3.68	$-.55	$-3.68
Diluted EPS	$-3.68	$-.55	$-3.68
Revenue	$638.5M	$196M	$638.5M
Gross Profit
Net Income / Loss	$-183.17M	$-28.56M	$-183.17M
Operating Income / Loss	$-166.76M	$-26.96M	$-166.76M
Cost of Revenue
Net Cash Flow	$7.58M	$-2.34M	$7.58M
PE Ratio